The Defense Logistics Agency (DLA) has awarded an indefinite delivery contract (IDC) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business organization based in Park Ridge, Illinois. The single-award IDC, valued at up to $4,999,999, enables DLA to issue firm fixed-price delivery orders against the contract for a wide range of pharmaceutical products to support the recurring medical supply needs of military health facilities worldwide. Major categories of goods to be delivered include naltrexone tablets, botulinum toxin injections, contraceptive implants and intrauterine devices, chemotherapy drugs, HIV antiretrovirals, ophthalmic solutions, injectable anesthetics, and other branded and generic medications spanning various therapeutic classes.
The IDC, contract number 4600082013 under the SPE2DB program, has a period of performance through December 31, 2025. This contract complements DMS Pharmaceutical Group's separate prime vendor agreements for direct distribution of prescription drugs and pharmacy services to Department of Defense sites. The company's woman-owned small business status has enabled direct awards for pharmaceutical Prime Vendor programs supporting military medical facilities globally, in collaboration with the Defense Logistics Agency and Veterans Health Administration.
Generated 5/7/24, 11:28 AM